RT Journal Article
SR Electronic
T1 A Queuing Model for Ventilator Capacity Management during the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.17.21253488
DO 10.1101/2021.03.17.21253488
A1 Zimmerman, Samantha L.
A1 Rutherford, Alexander R.
A1 van der Waall, Alexa
A1 Norena, Monica
A1 Dodek, Peter
YR 2022
UL http://medrxiv.org/content/early/2022/02/16/2021.03.17.21253488.abstract
AB We applied a queuing model to inform ventilator capacity planning during the first wave of the COVID-19 epidemic in the province of British Columbia (BC), Canada. The core of our framework is a multiclass Erlang loss model that represents ventilator use by both COVID-19 and non-COVID-19 patients. Input for the model includes COVID-19 case projections, and our analysis incorporates projections with different levels of transmission due to public health measures and social distancing. We incorporated data from the BC Intensive Care Unit Database to calibrate and validate the model. Using discrete event simulation, we projected ventilator access, including when capacity would be reached and how many patients would be unable to access a ventilator. Simulation results were compared with three numerical approximation methods, namely pointwise stationary approximation, modified offered load, and fixed point approximation. Using this comparison, we developed a hybrid optimization approach to efficiently identify required ventilator capacity to meet access targets. Model projections demonstrate that public health measures and social distancing potentially averted up to 50 deaths per day in BC, by ensuring that ventilator capacity was not reached during the first wave of COVID-19. Without these measures, an additional 173 ventilators would have been required to ensure that at least 95% of patients can access a ventilator immediately. Our model provides a tool for policy makers to quantify the interplay between public health measures, necessary critical care resources, and performance indicators for patient access.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a Partnership & Innovation Grant from the British Columbia Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Office of Research Ethics, Simon Fraser University, approved this study on the grounds that it is Quality Improvement / Quality Assurance.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA github reference is given in the manuscript for BC Centre for Disease Control case projections used in the model. https://github.com/bcgov/epi.branch.sim